NCT04792489 2025-04-24DALY II USA/ MB-CART2019.1 for DLBCLMiltenyi Biomedicine GmbHPhase 2 Recruiting248 enrolled
NCT06415708 2024-05-16Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell LymphomaInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 2 Recruiting134 enrolled